These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38965528)

  • 1. Prevalence and disease burden of chronic cough in nine cities of China: an observational study.
    Chen L; Lao KSJ; Yi F; Xia K; Lai K
    BMC Pulm Med; 2024 Jul; 24(1):322. PubMed ID: 38965528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data.
    Huang Y; Vemer P; Zhu J; Postma MJ; Chen W
    PLoS One; 2016; 11(8):e0159297. PubMed ID: 27570976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
    Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
    Zhang H; Zhang C; Zhu S; Ye H; Zhang D
    BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China.
    Zhang S; Ma Q; Liang S; Xiao H; Zhuang G; Zou Y; Tan H; Liu J; Zhang Y; Zhang L; Feng X; Xue L; Hu D; Cui F; Liang X
    J Viral Hepat; 2016 Mar; 23(3):202-10. PubMed ID: 26663525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.
    He X; Lloyd E; Cooper S; Li L; Chauhan D; Juliao P; Quasny H; Bao C
    Value Health Reg Issues; 2023 Sep; 37():88-96. PubMed ID: 37379801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual epidemiological and health insurance disease burden of hip osteoarthritis in Hungary based on nationwide data.
    Kajos LF; Molics B; Elmer D; Pónusz-Kovács D; Kovács B; Horváth L; Csákvári T; Bódis J; Boncz I
    BMC Musculoskelet Disord; 2024 May; 25(1):406. PubMed ID: 38783258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden and impact of chronic cough in UK primary care: a dataset analysis.
    Hull JH; Langerman H; Ul-Haq Z; Kamalati T; Lucas A; Levy ML
    BMJ Open; 2021 Dec; 11(12):e054832. PubMed ID: 34921086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data.
    Nazareth TA; Kariburyo F; Kirkemo A; Xie L; Pavlova-Wolf A; Bartels-Peculis L; Vaidya N; Sim JJ
    J Manag Care Spec Pharm; 2019 Sep; 25(9):1011-1020. PubMed ID: 31283419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.
    Al Dallal SAM; Farghaly M; Ghorab A; Elaassar M; Haridy H; Awad N; Chickballapur Ramachandrachar B; Natarajan A
    PLoS One; 2021; 16(9):e0256856. PubMed ID: 34469441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
    Krüger K; von Hinüber U; Meier F; Tian H; Böhm K; Jugl SM; Borchert K; Meise D; König C; Braun S
    Rheumatol Int; 2018 Nov; 38(11):2121-2131. PubMed ID: 30094685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.
    Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT; Doshi JA
    J Med Econ; 2014 Feb; 17(2):148-58. PubMed ID: 24168640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
    Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
    Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
    Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
    BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.